Kembali ke Daftar Obat

Panduan penyiapan dan pemberian terapi medikasi
Levofloxacin

Penyiapan

Sediaan

  • 500 mg/100 mL

Rekomendasi Pengenceran (Konsentrasi)

Pelarut

  • D5%
  • NaCl 0.9%

Pemberian

Rekomendasi Akses

IV

Rekomendasi Durasi Pemberian

500mg dalam 60 menit
750mg dalam 90 menit

Stabilitas Obat Setelah Rekonstruksi

24 jam dibawah suhu 25 derajat celcius

Keamanan

pH

3,8-5,8
pH risiko sedang (4,0-5,0 / 7,5-9,0)

Osmolaritas Sebelum Pengenceran

250
Osmolaritas rendah (<600)

Phlebitis

Tidak

Inkompatibilitas

  • Mannitol
  • Micafungin Sodium
  • Sodium Bicarbonate
  • Acyclovir Sodium
  • Alprostadil
  • Azithromycin
  • Furosemide
  • Heparin sodium
  • Indomethacin sodium trihydrate
  • Letermovir
  • Nitroglycerin
  • Plazomicin sulfate
  • Sodium nitroprusside
  • Telavancin HCl

Klasifikasi GHS

Irritant
Health Hazard

Manifestasi GHS

H302 (98.3%): Harmful if swallowed [Warning Acute toxicity, oral]
H317 (96%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H334 (97.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H361 (54.6%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H362 (53.4%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]

Sumber

  • American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850